{"id":"progestagen","rwe":[],"tags":[],"phase":"discontinued","safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"status":"discontinued","trials":["NCT03043924","NCT00928538","NCT05760144","NCT04624568","NCT03620929","NCT04385667","NCT05903131","NCT00401219","NCT05112692","NCT03456570","NCT07028242","NCT06396390","NCT05479448","NCT04897217","NCT02002260","NCT02792517","NCT00127075","NCT05670353","NCT03077698","NCT04050592","NCT01499602","NCT03585712","NCT01178788","NCT01813162","NCT01166412","NCT00064766","NCT07204093","NCT00319566","NCT03625531","NCT00697255","NCT05521828","NCT02404038","NCT00229593","NCT06637189","NCT00377988","NCT05050357","NCT01623466","NCT02412072","NCT00214903","NCT03436303","NCT00000466","NCT03921736","NCT00000419","NCT00864136","NCT06073184","NCT07077876","NCT02594462","NCT06379113","NCT02969590","NCT00005220"],"aliases":["Any other treatment for the indication as per cohort A or cohort B"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"aiSummary":"","brandName":"Progestagen","companyId":"center-for-epidemiology-and-health-research-germany","ecosystem":[],"mechanism":{"target":"","novelty":"","modality":"Small molecule","drugClass":"","explanation":"","oneSentence":"","technicalDetail":""},"commercial":null,"references":[],"biosimilars":[],"companyName":"Center for Epidemiology and Health Research, Germany","competitors":[],"dataSources":[{"url":"https://clinicaltrials.gov","name":"ClinicalTrials.gov","fields":["trialDetails","trials"],"retrievedDate":"2026-04-07"}],"genericName":"Progestagen","indications":{"approved":[],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT03043924","phase":"NA","title":"Functional Study of the Hypothalamus in High-resolution Magnetic Resonance Imaging (MRI) in Women With Polycystic Ovary Syndrome (PCOS): a Comparative Study","status":"COMPLETED","sponsor":"University Hospital, Lille","isPivotal":false,"enrollment":52,"indication":"Polycystic Ovary Syndrome","completionDate":"2022-04-15"},{"nctId":"NCT00928538","phase":"Phase 4","title":"Effectiveness of Home Based Distribution of Hormonal Contraceptives for Women at Risk for Unintended Pregnancy","status":"COMPLETED","sponsor":"Oregon Health and Science University","isPivotal":false,"enrollment":344,"indication":"Pregnancy, Effective Contraceptive Use","completionDate":"2015-05"},{"nctId":"NCT05760144","phase":"EARLY/Phase 1","title":"Endometrial Biopsy in Progestin Contraceptive Users","status":"RECRUITING","sponsor":"Oregon Health and Science University","isPivotal":false,"enrollment":52,"indication":"Contraception","completionDate":"2026-11"},{"nctId":"NCT04624568","phase":"NA","title":"Papilocare®: Effects on Regression of Histologically Confirmed Cervical Intraepithelial Lesions 1 and Tolerance.","status":"COMPLETED","sponsor":"Centre Hospitalier Régional d'Orléans","isPivotal":false,"enrollment":81,"indication":"Squamous Intraepithelial Lesions of the Cervix, Human Papilloma Virus Infection","completionDate":"2023-05-17"},{"nctId":"NCT03620929","phase":"Phase 4","title":"The Effect of Estrogen in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis","status":"UNKNOWN","sponsor":"Fu Xing Hospital, Capital Medical University","isPivotal":false,"enrollment":186,"indication":"Asherman Syndrome","completionDate":"2022-12-01"},{"nctId":"NCT04385667","phase":"Phase 2","title":"The Efficacy of Levonorgestrel Intrauterine System Versus Oral Megesterol Acetate in Treatment of Atypical Endometrial Hyperplasia. A Randomized Controlled Trial.","status":"COMPLETED","sponsor":"Zagazig University","isPivotal":true,"enrollment":143,"indication":"Atypical Endometrial Hyperplasia","completionDate":"2022-12-25"},{"nctId":"NCT05903131","phase":"Phase 2","title":"UPLifT-Endo: Uterine Preservation Via Lifestyle Transformation A Behavioral Intervention to Promote Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Atypical Endomet","status":"RECRUITING","sponsor":"Washington University School of Medicine","isPivotal":false,"enrollment":96,"indication":"Endometrial Hyperplasia, Grade 1 Endometrial Cancer","completionDate":"2029-10-31"},{"nctId":"NCT00401219","phase":"Phase 1","title":"An Open-Label, Single-Dose, Randomized, 4-Period, Crossover, Bioavailability Study Among 3 New Formulations of Premarin 0.625 mg/Medroxyprogesterone Acetate (Mpa) 2.5 mg Compared With a Reference Form","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","isPivotal":false,"enrollment":0,"indication":"Estrogen Replacement Therapy","completionDate":"2007-02"},{"nctId":"NCT05112692","phase":"NA","title":"Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI Cycles","status":"UNKNOWN","sponsor":"Mansoura University","isPivotal":false,"enrollment":200,"indication":"PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries","completionDate":"2023-12"},{"nctId":"NCT03456570","phase":"EARLY/Phase 1","title":"The Efficacy of Progestins in Treatment of Functional Ovarian Cyst","status":"UNKNOWN","sponsor":"Assiut University","isPivotal":false,"enrollment":90,"indication":"Functional Ovarian Cyst, Progesterone","completionDate":"2020-09-01"},{"nctId":"NCT07028242","phase":"N/A","title":"Ultrasound and Histological Features of Patients With Atypical Endometrial Hyperplasia and Early Endometrioid Endometrial Carcinoma Submitted to Fertility Sparing Treatment.","status":"NOT_YET_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","isPivotal":false,"enrollment":50,"indication":"Fertility-Sparing Treatment (FST), Atypical Endometrial Hyperplasia","completionDate":"2027-06-30"},{"nctId":"NCT06396390","phase":"Phase 4","title":"The Comparative Results of Progestin Primed Ovarian Stimulation (PPOS) and GnRH Antagonist Ovarian Stimulation Methods on IVF Outcomes","status":"NOT_YET_RECRUITING","sponsor":"Nesta Clinic","isPivotal":false,"enrollment":152,"indication":"IVF, Fertility Issues","completionDate":"2026-08-01"},{"nctId":"NCT05479448","phase":"N/A","title":"Predictive Factors for Treatment Response in Patients With Newly-diagnosed Polymyalgia Rheumatica and Giant Cell Arteritis","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","isPivotal":false,"enrollment":30,"indication":"Polymyalgia Rheumatica (PMR), Giant Cell Arteritis (GCA)","completionDate":"2028-12"},{"nctId":"NCT04897217","phase":"Phase 3","title":"Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in the Management of Atypical Endometrial Hyperplasia: A Non-Inferiority Study","status":"WITHDRAWN","sponsor":"Wake Forest University Health Sciences","isPivotal":true,"enrollment":0,"indication":"Endometrial Hyperplasia","completionDate":"2026-11"},{"nctId":"NCT02002260","phase":"NA","title":"Levonorgestrel Intrauterine System Versus Oral Contraceptives for Heavy Menses","status":"UNKNOWN","sponsor":"Women and Infants Hospital of Rhode Island","isPivotal":false,"enrollment":59,"indication":"Abnormal Uterine Bleeding, Abnormal Uterine Bleeding, Ovulatory Dysfunction","completionDate":"2021-12-31"},{"nctId":"NCT02792517","phase":"Phase 1","title":"A Multi-Center, Open-label, Pharmacokinetic Drug Interaction Study of AMG 334 and a Combined Oral Contraceptive in Healthy Female Subjects","status":"COMPLETED","sponsor":"Amgen","isPivotal":false,"enrollment":41,"indication":"Headache, Migraine","completionDate":"2016-09-09"},{"nctId":"NCT00127075","phase":"Phase 3","title":"POPART'MUS: Prevention of Post Partum Relapses With Progestin and Estradiol in Multiple Sclerosis","status":"UNKNOWN","sponsor":"Hospices Civils de Lyon","isPivotal":true,"enrollment":300,"indication":"Multiple Sclerosis","completionDate":"2012-04"},{"nctId":"NCT05670353","phase":"Phase 2","title":"Cannabidiol in the Treatment of Women With Chronic Pelvic Pain Secondary to Endometriosis","status":"TERMINATED","sponsor":"University of Sao Paulo","isPivotal":true,"enrollment":50,"indication":"Endometriosis, Pelvic Pain","completionDate":"2024-11-20"},{"nctId":"NCT03077698","phase":"Phase 2","title":"A Phase 2, Single Arm, Two Period Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Endometrial Carcinoma","status":"TERMINATED","sponsor":"Xenetic Biosciences, Inc.","isPivotal":false,"enrollment":25,"indication":"Endometrial Cancer","completionDate":"2020-07-17"},{"nctId":"NCT04050592","phase":"Phase 4","title":"Randomized Comparative Trial Between Abrupt and Tapered Discontinuation of Postmenopausal Hormone Therapy: Impact on Endothelial Function, Recurrence of Vasomotor Symptoms and Quality of Life","status":"UNKNOWN","sponsor":"Hanna Savolainen-Peltonen","isPivotal":false,"enrollment":150,"indication":"Menopause, Atherosclerosis","completionDate":"2022-12"},{"nctId":"NCT01499602","phase":"NA","title":"LNG-IUS or Norethisterone Acetate for Treatment of Non-atypical Endometrial Hyperplasia in Perimenopausal Women","status":"COMPLETED","sponsor":"Mansoura University","isPivotal":false,"enrollment":120,"indication":"Endometrial Hyperplasia","completionDate":"2011-11"},{"nctId":"NCT03585712","phase":"Phase 2","title":"A Prospective, Multi-center, Randomized, Cross-over Study to Assess the Effect of Norgestrel 75 mcg on Cervical Mucus and Ovarian Activity During Perfect Use, After One Delayed Intake and After a Miss","status":"COMPLETED","sponsor":"HRA Pharma","isPivotal":false,"enrollment":52,"indication":"Contraception","completionDate":"2020-04-07"},{"nctId":"NCT01178788","phase":"Phase 3","title":"Progestagens for the Tertiary Prophylaxis of Preterm Delivery in Women With Short Cervix. A Randomized Multicentre Trial","status":"COMPLETED","sponsor":"University of Modena and Reggio Emilia","isPivotal":true,"enrollment":254,"indication":"Preterm Delivery, Neonatal Complications","completionDate":"2015-12"},{"nctId":"NCT01813162","phase":"Phase 1","title":"In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products","status":"COMPLETED","sponsor":"CONRAD","isPivotal":false,"enrollment":101,"indication":"HIV Prevention","completionDate":"2014-12"},{"nctId":"NCT01166412","phase":"Phase 1","title":"CCN009: A Multi-center, Open-label, Randomized, Parallel Group Study to Evaluate the Effects on the Mechanisms of Contraceptive Efficacy and, Secondarily, to Assess the Pharmacokinetic Profile and Saf","status":"COMPLETED","sponsor":"Premier Research","isPivotal":false,"enrollment":121,"indication":"Contraception","completionDate":"2012-07"},{"nctId":"NCT00064766","phase":"Phase 4","title":"A Prospective Randomized Clinical Trial of Doxycycline 20mg Twice a Day Versus Placebo on the Bleeding and Spotting in Women After Insertion of a Levonorgestrel Implant (Norplant) Protocol #2002-1","status":"UNKNOWN","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","isPivotal":false,"enrollment":50,"indication":"Endometrial Bleeding, Periodontal Disease","completionDate":"2005-02"},{"nctId":"NCT07204093","phase":"N/A","title":"Transdermally Applied Estradiol Delivery In Ultra-Safe Medications Valuable In Treatment Against Endometriosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","isPivotal":false,"enrollment":138,"indication":"Endometriosis","completionDate":"2026-02"},{"nctId":"NCT00319566","phase":"Phase 3","title":"Heart and Estrogen-Progestin Replacement Study (HERS)","status":"COMPLETED","sponsor":"University of California, San Francisco","isPivotal":true,"enrollment":2430,"indication":"Coronary Heart Disease","completionDate":"2001-07"},{"nctId":"NCT03625531","phase":"Phase 3","title":"A Multicenter Randomized Trial of Personalized Acupuncture, Fixed Acupuncture, Letrozole and Placebo on Live Birth for Infertility in Women With Polycystic Ovary Syndrome","status":"UNKNOWN","sponsor":"Hongxia Ma","isPivotal":true,"enrollment":1100,"indication":"Polycystic Ovary Syndrome","completionDate":"2024-01-31"},{"nctId":"NCT00697255","phase":"Phase 2","title":"A Phase II, Randomized, Controlled, Open-label, Feasibility Trial to Evaluate if a Single or Repeated Dose of Org 36286 (Corifollitropin Alfa) Followed by a Low Daily Dose of Either hCG or Recombinant","status":"TERMINATED","sponsor":"Organon and Co","isPivotal":false,"enrollment":8,"indication":"Ovulation Induction","completionDate":"2008-05-15"},{"nctId":"NCT05521828","phase":"NA","title":"Luteal Phase Ovarian Stimulation With Follitropin Delta and Dydrogesterone: a Randomized Cross Over Pilot Trial","status":"UNKNOWN","sponsor":"CRG UZ Brussel","isPivotal":false,"enrollment":50,"indication":"Oocyte Donors, Oocyte Donation","completionDate":"2024-12-31"},{"nctId":"NCT02404038","phase":"NA","title":"An Open-Label, Randomized Crossover Study to Evaluate the Acceptability and Preference for Contraceptive Options in Healthy HIV-Uninfected Female Adolescents, 16-17 Years of Age, as Proxy for HIV Prev","status":"UNKNOWN","sponsor":"Desmond Tutu HIV Centre","isPivotal":false,"enrollment":131,"indication":"HIV","completionDate":"2020-02-28"},{"nctId":"NCT00229593","phase":"Phase 1","title":"A Randomized, Open Label Clinical Trial to Evaluate if Nestorone Gel Has Gonadotropin Suppressive Activity and if Nestorone in Combination With Testosterone Will Have an Additive Effect on Gonadotropi","status":"COMPLETED","sponsor":"University of Washington","isPivotal":false,"enrollment":140,"indication":"Contraception","completionDate":"2007-01"},{"nctId":"NCT06637189","phase":"Phase 4","title":"Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the Beginning of Stimulation Versus Protocol with GnRH Antagonists for Ovarian Stimulation in Patients Undergoing DUOSTIM with Embryo Acc","status":"NOT_YET_RECRUITING","sponsor":"Ginefiv","isPivotal":false,"enrollment":144,"indication":"Stimulation in the Ovary, Embryo","completionDate":"2025-12-31"},{"nctId":"NCT00377988","phase":"N/A","title":"The Risk of Venous Thromboembolism, Myocardial Infarction, and Ischemic Stroke Among Women Using the Transdermal Contraceptive System Compared With Women Using Norgestimate-containing Oral Contracepti","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","isPivotal":false,"enrollment":423,"indication":"Contraception, Female Contraception","completionDate":"2008-10"},{"nctId":"NCT05050357","phase":"NA","title":"Effectiveness of Hormonal Intrauterine Device in Treating Pelvic Congestion Syndrome Compared to Oral Progestin","status":"COMPLETED","sponsor":"Assiut University","isPivotal":false,"enrollment":104,"indication":"Pelvic Congestion","completionDate":"2023-02-01"},{"nctId":"NCT01623466","phase":"Phase 1","title":"A Randomized, Open-Label, Parallel Group Study To Evaluate Pharmacokinetic Profile, Wearability And Safety of Two Progestin-Only Patches Containing Different Doses Of Levonorgestrel (LNG)","status":"COMPLETED","sponsor":"Agile Therapeutics","isPivotal":false,"enrollment":36,"indication":"Healthy","completionDate":"2012-09"},{"nctId":"NCT02412072","phase":"N/A","title":"","status":"UNKNOWN","sponsor":"Korean Gynecologic Oncology Group","isPivotal":false,"enrollment":75,"indication":"Endometrial Hyperplasia","completionDate":"2017-12"},{"nctId":"NCT00214903","phase":"N/A","title":"European Active Surveillance Study of Women Taking HRT","status":"COMPLETED","sponsor":"Center for Epidemiology and Health Research, Germany","isPivotal":false,"enrollment":30597,"indication":"Menopausal Symptoms","completionDate":"2011-11"},{"nctId":"NCT03436303","phase":"Phase 4","title":"The Effect and Risk of Conjugated Estrogens Combined With Different Types of Progestin in the Treatment of Menopause Syndrome During Window Phase","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","isPivotal":false,"enrollment":120,"indication":"Menopause Syndrome","completionDate":"2018-12-01"},{"nctId":"NCT00000466","phase":"Phase 3","title":"","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","isPivotal":true,"enrollment":0,"indication":"Bone Diseases, Cardiovascular Diseases","completionDate":"2000-10"},{"nctId":"NCT03921736","phase":"Phase 4","title":"Reversal of an Unfavorable Effect of Hydrochlorothiazide Compared to Angiotensin Converting Enzyme Inhibitor on Serum Uric Acid and Oxypurines Levels by Estrogen-progestin Therapy in Hypertensive Post","status":"COMPLETED","sponsor":"Anna Posadzy-Małaczyńska","isPivotal":false,"enrollment":180,"indication":"Hypertension, Hyperuricemia","completionDate":"2005-11-17"},{"nctId":"NCT00000419","phase":"Phase 3","title":"Safety of Estrogens in Lupus Erythematosus - National Assessment (SELENA): Hormone Replacement Therapy","status":"TERMINATED","sponsor":"NYU Langone Health","isPivotal":true,"enrollment":350,"indication":"Systemic Lupus Erythematosus","completionDate":"2002-08"},{"nctId":"NCT00864136","phase":"N/A","title":"MiCo - Mirena or Conventional Medical Treatment for Menorrhagia","status":"COMPLETED","sponsor":"Bayer","isPivotal":false,"enrollment":647,"indication":"Menorrhagia","completionDate":"2010-11"},{"nctId":"NCT06073184","phase":"Phase 2","title":"Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium (WE-FiERCE)","status":"NOT_YET_RECRUITING","sponsor":"University Health Network, Toronto","isPivotal":false,"enrollment":71,"indication":"Endometrial Cancer, Atypical Hyperplasia","completionDate":"2032-02"},{"nctId":"NCT07077876","phase":"N/A","title":"Surgical and Obstetric Outcomes in Patients With Endometrial Adenocarcinoma and Atypical Endometrial Hyperplasia Undergoing Conservative Treatment","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","isPivotal":false,"enrollment":100,"indication":"Endometrial Adenocarcinoma, Endometrial Hyperplasia","completionDate":"2026-01-20"},{"nctId":"NCT02594462","phase":"Phase 4","title":"Use of Etonogestrel-releasing Contraceptive Implant in Women With Sickle Cell Disease","status":"COMPLETED","sponsor":"University of Sao Paulo","isPivotal":false,"enrollment":29,"indication":"Sickle Cell Disease","completionDate":"2019-06"},{"nctId":"NCT06379113","phase":"Phase 2","title":"Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole in Obese Progestin-insensitive Early-stage Endometrial Cancer Patients With Conservative Treatment","status":"RECRUITING","sponsor":"Xiaojun Chen","isPivotal":true,"enrollment":29,"indication":"Endometrial Neoplasms, Atypical Endometrial Hyperplasia","completionDate":"2027-03-30"},{"nctId":"NCT02969590","phase":"Phase 4","title":"Regulation of Cervical Mucus Secretion","status":"COMPLETED","sponsor":"Oregon Health and Science University","isPivotal":false,"enrollment":5,"indication":"Fertility, Contraception","completionDate":"2017-08-23"},{"nctId":"NCT00005220","phase":"N/A","title":"","status":"COMPLETED","sponsor":"University of Washington","isPivotal":false,"enrollment":0,"indication":"Cardiovascular Diseases, Heart Diseases","completionDate":"1999-01"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"icon":"","route":"","frequency":"","formulation":""},"formularyStatus":[],"apiManufacturers":[],"developmentCodes":[],"ownershipHistory":[],"therapeuticAreas":["Other"],"biosimilarFilings":[],"firstApprovalDate":"","companionDiagnostics":[],"firstApprovalCountry":null,"genericManufacturerList":[],"modality":"Small molecule","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}